PT Medikaloka Hermina Tbk

Jakarta Stock Exchange HEAL.JK

PT Medikaloka Hermina Tbk EBITDA for the year ending December 31, 2023: USD 102.99 M

PT Medikaloka Hermina Tbk EBITDA is USD 102.99 M for the year ending December 31, 2023, a 37.04% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

PT Medikaloka Hermina Tbk EBITDA for the year ending December 31, 2022 was USD 75.15 M, a -51.75% change year over year.
PT Medikaloka Hermina Tbk EBITDA for the year ending December 31, 2021 was USD 155.75 M, a 62.44% change year over year.
PT Medikaloka Hermina Tbk EBITDA for the year ending December 31, 2020 was USD 95.88 M, a 64.23% change year over year.
PT Medikaloka Hermina Tbk EBITDA for the year ending December 31, 2019 was USD 58.38 M, a 42.52% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Jakarta Stock Exchange: HEAL.JK

PT Medikaloka Hermina Tbk

CEO	Dr. H. Hasmoro M.H.A., M.M.
IPO Date	May 17, 2018
Location	Indonesia
Headquarters	Hermina Tower
Employees	18,231
Sector	Health Care
Industries Hospitals & Clinics Telehealth

Description

PT Medikaloka Hermina Tbk operates a network of general hospitals in Indonesia. As of December 31, 2021, the company operated 43 hospitals with 5,877 beds. It is also involved in the investment and education service businesses. The company was founded in 1985 and is based in Jakarta, Indonesia.

Key trends

Past 5 years